News

Can-Fite

CAN-FITE expands license deal with Ewopharma

Exclusive distribution agreement for psoriasis and hepatocellular carcinoma (HCC) and nonalcoholic steatohepatitis (NASH).

Mediwound

Mediwound announces positive data from clinical study

Phase I/II study evaluated safety and efficacy of MW005 for low-risk Basal Cell Carcinoma (BCC).

Cathworks

Cathworks announces first patient in clinical trial

Evaluates the clinical benefits of FFRangio® System in coronary artery disease (CAD)

Nanox

Nanox.AI New Global Partnership with Ferrum Health

Partnership on AI platform – Bone solution (HealthOST) and cardiac solution (HealthCCSng)

Exero

Unorthodox Ventures Invests in Exero Medical

Unorthodox and Founder Carey Smith provide bridge financing toward a series A round

DiA

DiA Secures FDA Clearance for its New AI Software

LVivo IQS for cardiac ultrasound users with real-time image quality feedback while scanning

Mor Research Applications

Purple Biotech Inks Deal With Mor

The agreement provides Purple first access to early-stage oncology product candidates owned by Mor

12